AIM ImmunoTech Inc (AMEX:AIM) price on Wednesday, February 05, fall -20.88% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.14.
A look at the stock’s price movement, the close in the last trading session was $0.18, moving within a range at $0.131 and $0.18. The beta value (5-Year monthly) was -0.363. Turning to its 52-week performance, $0.62 and $0.16 were the 52-week high and 52-week low respectively. Overall, AIM moved -38.97% over the past month.
AIM ImmunoTech Inc’s market cap currently stands at around $9.80 million, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 100k for the company’s revenue for the quarter, with a low and high estimate of 100k and 100k respectively. The average forecast suggests up to a 53.85% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 200k, representing a -0.99% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AIM is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AIM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AIM’s current price about -29.92% and -31.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 26.16, while 7-day volatility ratio is 14.54% and 10.74% in the 30-day chart. Further, AIM ImmunoTech Inc (AIM) has a beta value of 0.37, and an average true range (ATR) of 0.02.
If we refocus on AIM ImmunoTech Inc (AMEX:AIM), historical trading data shows that trading volumes averaged 0.83 over the past 10 days and 662.59K over the past 3 months. The company’s latest data on shares outstanding shows there are 68.75 million shares.
The 11.89% of AIM ImmunoTech Inc’s shares are in the hands of company insiders while institutional holders own 13.14% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.49 million on 2024-10-31, giving us a short ratio of 1.63. The data shows that as of 2024-10-31 short interest in AIM ImmunoTech Inc (AIM) stood at 85.00000000000001 of shares outstanding, with shares short falling to 0.59 million registered in 2024-09-30. Current price change has pushed the stock -28.03% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AIM stock continues to rise going into the next quarter.
